The guanosine-adenosine interaction exists in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 350, Issue 3, 2014, Pages 719-726

  Jackson, Edwin K ^a   Mi, Zaichuan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; GUANOSINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE RELEASE; GLOMERULUS FILTRATION RATE; IN VIVO STUDY; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SYSTEMIC VASCULAR RESISTANCE; URINARY EXCRETION; ANIMAL; BLOOD; DRUG INTERACTION; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE; ANIMALS; DRUG INTERACTIONS; GUANOSINE; INFUSIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84907284416     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.216978     Document Type: Article

References (46)

1. Begany DP, Carcillo JA, Herzer WA, Mi Z, and Jackson EK (1996) Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure. J Pharmacol Exp Ther 278:37-41.
2. 2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. Prog Neurobiol 83:310-331.
3. Colgan SP, Fennimore B, and Ehrentraut SF (2013) Adenosine and gastrointestinal inflammation. J Mol Med (Berl) 91:157-164.
4. Dal-Cim T, Ludka FK, Martins WC, Reginato C, Parada E, Egea J, López MG, and Tasca CI (2013) Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. J Neurochem 126:437-450.
5. 2A adenosine receptors on bone marrow-derived cells. J Clin Invest 112:883-891.
6. Day Y-J, Huang L, Ye H, Linden J, and Okusa MD (2005) Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 288:F722-F731.
7. Fitzpatrick JM, Wallace DM, Whitfield HN, Watkinson LE, Fernando AR, and Wickham JE (1981) Inosine in ischaemic renal surgery: long-term follow-up. Br J Urol 53: 524-527.
8. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, and Müller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors: an update. Pharmacol Rev 63:1-34.
9. Giuliani P, Ballerini P, Ciccarelli R, Buccella S, Romano S, D'Alimonte I, Poli A, Beraudi A, Peña E, Jiang S, et al. (2012) Tissue distribution and metabolism of guanosine in rats following intraperitoneal injection. J Biol Regul Homeost Agents 26:51-65.
10. Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, Tak E, McNamee EN, Clambey E, Moldovan R, and Reyes G, et al. (2012) Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 122:693-710.
11. Grenz A, Homann D, and Eltzschig HK (2011) Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxid Redox Signal 15:2221-2234.
12. 2B adenosine receptor protects the kidney from ischemia. PLoS Med 5:e137.
13. Grenz A, Zhang H, Eckle T, Mittelbronn M, Wehrmann M, Köhle C, Kloor D, Thompson LF, Osswald H, and Eltzschig HK (2007a) Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol 18:833-845.
14. Grenz A, Zhang H, Hermes M, Eckle T, Klingel K, Huang DY, Müller CE, Robson SC, Osswald H, and Eltzschig HK (2007b) Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 21:2863-2873.
15. Haskó G, Csóka B, Koscsó B, Chandra R, Pacher P, Thompson LF, Deitch EA, Spolarics Z, Virág L, Gergely P, et al. (2011) Ecto-5′-nucleotidase (CD73) decreases mortality and organ injury in sepsis. J Immunol 187:4256-4267.
16. Haskó G, Pacher P, Deitch EA, and Vizi ES (2007) Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 113:264-275.
17. Jackson EK, Cheng D, Jackson TC, Verrier JD, and Gillespie DG (2013) Extracellular guanosine regulates extracellular adenosine levels. Am J Physiol Cell Physiol 304: C406-C421.
18. Jackson EK, Cheng D, Mi Z, and Gillespie DG (2014) Guanosine regulates adenosine levels in the kidney. Physiol Rep 2:e12028.
19. Jackson EK and Gillespie DG (2013) Regulation of cell proliferation by the guanosine-adenosine mechanism: role of adenosine receptors. Physiol Rep 1: e00024.
20. Jackson EK, Ren J, and Mi Z (2009) Extracellular 2′,3′-cAMP is a source of adenosine. J Biol Chem 284:33097-33106.
21. Kelly KJ, Plotkin Z, and Dagher PC (2001) Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 108:1291-1298.
22. 1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int 75: 809-823.
23. 3 receptors. Am J Physiol Renal Physiol 278:F380-F387.
24. 2A adenosine receptors. Am J Physiol Renal Physiol 282:F844-F852.
25. 1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 15:102-111.
26. 1 adenosine receptor expression. Kidney Int 71:1249-1261.
27. 1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 286:F298-F306.
28. Longhi MS, Robson SC, Bernstein SH, Serra S, and Deaglio S (2013) Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. J Mol Med (Berl) 91:165-172.
29. Maggio AJ, Jr, Das S, Smith RB, and Kaufman JJ (1980) Renal preservation with inosine. Urology 16:343-345.
30. Marberger M, Günther R, Alken P, Rumpf W, and Ranc M (1980) Inosine: alternative or adjunct to regional hypothermia in the prevention of post-ischemic renal failure? Eur Urol 6:95-102.
31. Mathur VK and Ramsey EW (1983) Comparison of methods for preservation of renal function during ischemic renal surgery. J Urol 129:163-165.
32. Ohta A and Sitkovsky M (2009) The adenosinergic immunomodulatory drugs. Curr Opin Pharmacol 9:501-506.
33. 2A adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol 282:F10-F18.
34. 2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279:F809-F818.
35. 2A-adenosine receptor activation and PDE 4 inhibition. Kidney Int 59:2114-2125.
36. 2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol 277:F404-F412.
37. Poth JM, Brodsky K, Ehrentraut H, Grenz A, and Eltzschig HK (2013) Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease. J Mol Med (Berl) 91:183-193.
38. Rothwell D, Bartley J, and James M (1981) Preservation of the ischaemic canine kidney with inosine. Urol Res 9:75-78.
39. Shen H, Chen G-J, Harvey BK, Bickford PC, and Wang Y (2005) Inosine reduces ischemic brain injury in rats. Erratum appears in Stroke. 2005 May;36 5 :1106 Note: Dosage error in article text Stroke 36:654-659.
40. Shin DH, Choi KS, Cho BS, Song S, Moon D-C, Hong JT, Lee C-K, and Chung YB (2008) Pharmacokinetics of guanosine in rats following intravenous or intramuscular administration of a 1:1 mixture of guanosine and acriflavine, a potential antitumor agent. Arch Pharm Res 31:1347-1353.
41. Stone TW (2002) Purines and neuroprotection. Adv Exp Med Biol 513:249-280.
42. Stone TW, Forrest CM, Mackay GM, Stoy N, and Darlington LG (2007) Tryptophan, adenosine, neurodegeneration and neuroprotection. Metab Brain Dis 22: 337-352.
43. Thauerer B, Zur Nedden S, and Baier-Bitterlich G (2012) Purine nucleosides: endogenous neuroprotectants in hypoxic brain. J Neurochem 121:329-342.
44. Tofovic SP, Zacharia L, Carcillo JA, and Jackson EK (2001) Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats. Shock 16:196-202.
45. Traversa U, Bombi G, Camaioni E, Macchiarulo A, Costantino G, Palmieri C, Caciagli F, and Pellicciari R (2003) Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorg Med Chem 11:5417-5425.
46. Vallon V, Mühlbauer B, and Osswald H (2006) Adenosine and kidney function. Physiol Rev 86:901-940.